Accepted Article. Irritable bowel syndrome (IBS) subtypes: Nothing. Fermín Mearin Manrique. DOI: /reed /2016 Link: PDF
|
|
- Kenneth Houston
- 5 years ago
- Views:
Transcription
1 Accepted Article Irritable bowel syndrome (IBS) subtypes: Nothing resembles less an IBS than another IBS Fermín Mearin Manrique DOI: /reed /2016 Link: PDF Please cite this article as: Mearin Manrique Fermín. Irritable bowel syndrome (IBS) subtypes: Nothing resembles less an IBS than another IBS. Rev Esp Enferm Dig doi: /reed /2016. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
2 Editorial 4195 inglés Irritable bowel syndrome (IBS) subtypes: nothing resembles less an IBS than another IBS Fermín Mearin Instituto de Trastornos Funcionales. Chairman, Roma IV Committee on Functional Gastrointestinal Disorders. Centro Médico Teknon. Barcelona, Spain Two new members of IBS Patient Association met at a meeting. Feeling somewhat lost, not knowing anybody present, they introduced themselves to each other. After exchanging names, one asks the other - What s your problem? The other one answers - I got constipation that laxatives fail to relieve, and my belly, which is always bloated, sometimes hurts so much that I can t even leave home. Deeply surprised, the first individual inquires What are you doing here then? Why, I came to this meeting looking for some help for my irritable colon, she answered. Irritable colon? That s no irritable colon. Irritable bowel syndrome is what I suffer from, and it s diarrhea that won t let me be; can t stop running to the toilet, and cramps just pop up any time. Now both looked surprised. Both thought they had come to the wrong meeting, and both were on the verge of leaving. Luckily, the Association s secretary showed up and explained that both had IBS. As is well known, IBS clinical manifestations are highly variable and heterogeneous, and various symptom associations may develop. This includes both patients with abdominal pain and diarrhea, and individuals who suffer from constipation, with abdominal distension or bloating also representing a common finding (1). Furthermore, patients with IBS usually report symptoms characteristic of other functional disorders, whether digestive or otherwise. Thus, about half of IBS cases have gastroesophageal reflux disease (GERD) or functional dyspepsia (2,3), and IBS is also commonly associated with fibromyalgia, chronic fatigue syndrome, interstitial cystitis, tensional headache, etc. (4,5).
3 Most outstanding, possibly, is the fact that this syndrome includes both patients with constipation and patients with diarrhea, or even individuals where these two symptoms alternate. This is why, according to the Rome II criteria, three IBS subtypes were described years ago: 1. With predominant constipation; 2. With predominant diarrhea; and 3. With mixed bowel pattern (6). Subtypes were established according to the following symptoms: 1. Fewer than 3 stools per week; 2. More than 3 stools per week; 3. Hard or ball-shaped feces; 4. Soft or liquid feces; 5. Straining during stool evacuation; 6. Urgency. Hence, the predominant constipation subtype is considered when 1, 3 and/or 5 and neither 2, nor 4 nor 6 are present; the predominant diarrhea subtype requires 2, 4 and/or 6 and none of 1, 3, 5; and the mixed subtype requires diarrhea/constipation changes not meeting the above two criteria. However, according to Rome III recommendations, subtypes were later defined according to stool consistency as assessed using the Bristol Stool Scale (7). Thus, when over 25% of stools correspond to type 1 or 2, the patient is deemed to suffer from IBS with constipation; when over 25% of stools are of type 6 or 7, the patient is considered to have IBS with diarrhea; when over 25% of both (1 or 2, 6 or 7) are present, IBS with mixed bowel habit is diagnosed; finally, when less than 25% of both are present, the case is said to be unspecified bowel pattern. The term alternating is restricted to changes along prolonged periods. The distribution of the various IBS subtypes is approximately one third for each subtype, although this may vary according to criteria and the population assessed (8,9). In turn, while stability over time is debated for these subtypes, the key fact is that the transition from constipation to diarrhea or vice versa is uncommon, whereas both subtypes may ultimately result in or from the mixed (or alternating) type (10,11). In the paper by Cristiane Kibune-Nagasako et al. (Campinas, São Paulo, Brazil) included in this issue of the Spanish Journal of Gastroenterology (Revista Española de Enfermedades Digestivas) the differences between IBS subtypes are again underscored (12). The authors conclude that IBS with mixed bowel habit (IBS-M) is characterized by both constipation and diarrhea (IBS-C and IBS-D) symptoms, which is obvious, and note that patients with this subtype suffer from higher anxiety and comorbidity levels, including GERD.
4 May this paper help recall IBS heterogeneity and the need to define cases according to each individual s predominant symptoms and associated complaints. Establishing an origin or primary pathophysiological mechanism for each case is also crucial. In fact, subtypes should not be limited to IBS-C, IBSI-D and IBS-M. When pain or distension/bloating predominates, IBS management differs, and the addition of subtypes such as IBS-P and IBS-B would seem logical. Similarly, IBS could be classified according to potential causes: IBS-post-infection (13), IBS-post-trauma (14), IBS-atopic (15), IBS-post-diverticulitis (16), IBS-associated with emotional factors (17), etc. Kibune-Nagasako et al. conclude in their paper that patients with IBS-M have special characteristics to be considered regarding their management. This mark-hitting claim should be extrapolated to all IBS subtypes and to each and every patient with this syndrome. As a matter of fact, in the above-mentioned IBS Patient Association meeting no two cases were exactly alike. REFERENCES1. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130: DOI: /j.gastro Balboa A, Mearin F, Badía X, et al. Impact of upper digestive symptoms in patients with irritable bowel syndrome. Eur J Gastroenterol 2006;18: DOI: /01.meg f 3. Gasiorowska A, Poh CH, Fass R. Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS) - Is it one disease or an overlap of two disorders? Dig Dis Sci 2009;54: Vandvik PO, Wilhelmsen I, Ihlebaek C, et al. Comorbidity of irritable bowel syndrome in general practice: A striking feature with clinical implications. Aliment Pharmacol Ther 2004;20: DOI: /j x 5. Whitehead WE, Palsson OS, Levy RR et al. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007;102: DOI: /j x 6. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Supl. 2): DOI: /gut ii43 7. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32: DOI: / Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome. Systematic review. Am J Gastroenterol Am J Gastroenterol
5 2005;100: DOI: /j x 9. Mearin F, Balboa A, Badía X, et al. Irritable bowel syndrome subtypes according to bowel habit: Revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003;15: DOI: / Mearin F, Lacy B. Diagnostic criteria in IBS: useful or not? Neurogastroenterol Motil 2012;24: Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in IBS: defining an alternator. Gastroenterology 2005;128: DOI: /j.gastro Kibune-Nagasako C, Garcia-Montes C, Silva-Lorena SL, et al. Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities. Rev Esp Enferm Dig 2016;108:xxx-xxx. 13. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007;26: DOI: /j x 14. Perona M, Benasayag R, Perelló A, et al. High prevalence of functional gastrointestinal disorders in women who report domestic violence to the police. Clin Gastroenterol Hepatol 2005;3: DOI: /S (04) Tobin MC, Moparty B, Farhadi A, et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol 2008;100: DOI: /S (10) Cohen E, Fuller G, Bolus R, et al. Increased risk for irritable bowel syndrome after acute diverticulitis. Clin Gastroenterol Hepatol 2013;11: DOI: /j.cgh Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011;140: DOI: /j.gastro
Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study)
Alimentary Pharmacology & Therapeutics Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study) V. GARRIGUES*, F. MEARIN, X.BADÍAà,
More informationIBS: overview and assessment of pain outcomes and implications for inclusion criteria
IBS: overview and assessment of pain outcomes and implications for inclusion criteria William D. Chey, MD Professor of Medicine University of Michigan What is the Irritable Bowel Syndrome Symptom based
More informationAlternating bowel pattern: what do people mean?
Alimentary Pharmacology & Therapeutics Alternating bowel pattern: what do people mean? R. S. CHOUNG*, G. R. LOCKE III*, A. R. ZINSMEISTER, L.J.MELTONIIIà &N.J.TALLEY* *Dyspepsia Center and Division of
More informationPrevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population
https://helda.helsinki.fi Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population Hillilä, M. T. 2004-08-01 Hillilä, M T & Färkkilä, MA 2004,
More informationPrevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria
ORIGINAL RESEARCH Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria Hiroto Miwa Division of Upper Gastroenterology, Department of Internal Medicine, Hyogo College
More informationThe burden and management of patients with IBS: results from a survey in Spanish gastroenterologists
1130-0108/2011/103/11/570-575 REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVAS Copyright 2011 ARÁN EDICIONES, S. L. REV ESP ENFERM DIG (Madrid) Vol. 103. N. 11, pp. 570-575, 2011 ORIGINAL PAPERS The burden
More informationTitle: Aerophagia due to abdomino-phrenic dyssynergia in a 2-year-old child. Authors: Pablo Ercoli, Belinda García, Enrique del Campo, Sergio Pinillos
Title: Aerophagia due to abdomino-phrenic dyssynergia in a 2-year-old child Authors: Pablo Ercoli, Belinda García, Enrique del Campo, Sergio Pinillos DOI: 10.17235/reed.2018.5444/2017 Link: PubMed (Epub
More informationSUPPLEMENTARY INFORMATION Associated with
Table1: Rome III and Rome IV diagnostic criteria for IBS, functional constipation and functional dyspepsia. Rome III diagnostic criteria 1,2 Rome IV diagnostic criteria 3,4 Diagnostic criteria for IBS
More informationA Prospective Assessment of Bowel Habit in Irritable Bowel Syndrome in Women: Defining an Alternator
GASTROENTEROLOGY 2005;128:580 589 A Prospective Assessment of Bowel Habit in Irritable Bowel Syndrome in Women: Defining an Alternator DOUGLAS A. DROSSMAN,* CAROLYN B. MORRIS,* YUMING HU,* BRENDA B. TONER,
More informationPrevalence of Functional Gastrointestinal Disorders in Women Who Report Domestic Violence to the Police
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:436 441 ORIGINAL ARTICLES Prevalence of Functional Gastrointestinal Disorders in Women Who Report Domestic Violence to the Police MÓNICA PERONA,* RUTH BENASAYAG,*
More informationDavid Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure:
David Leff, DO AOMA 94 th Annual Convention April 13, 2016 Disclosure I have the following financial relationships to disclosure: Speaker s Bureau: Allergan Labs, Takeda Pharmaceutical, Valeant Pharmaceutical
More informationGastrointestinal Society 2016 SURVEY RESULTS
Gastrointestinal Society 2016 SURVEY RESULTS Irritable Bowel Syndrome (IBS) The GI (Gastrointestinal) Society represents Canadians living with gastrointestinal diseases and disorders including those who
More information... SELECTED ABSTRACTS...
... SELECTED ABSTRACTS... The following abstracts, from medical journals containing literature on irritable bowel syndrome, were selected for their relevance to this supplement. A Technical Review for
More informationTitle: Perceptions of the public healthcare system from private-care patients with irritable bowel syndrome with constipation in Spain
Title: Perceptions of the public healthcare system from private-care patients with irritable bowel syndrome with constipation in Spain Authors: José Joaquín Mira, Glòria Lacima, Xavier Cortés Gil DOI:
More informationALMIRALL AND IRONWOOD ANNOUNCE POSITIVE RESULTS FROM A PHASE 3 TRIAL WITH LINACLOTIDE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION
FOR IMMEDIATE RELEASE Ironwood Contact: Almirall Contact: Susan Brady Ketchum Pleon Corporate Communications Amanda Sefton 617.621.8304 +44 (0) 207.611.3653 sbrady@ironwoodpharma.com amanda.sefton@ketchumpleon.com
More informationVicente Garrigues, Consuelo Gálvez, Vicente Ortiz, Marta Ponce, Pilar Nos, and Julio Ponce
American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 159, No. 5 Printed in U.S.A. DOI: 10.1093/aje/kwh072 PRACTICE OF EPIDEMIOLOGY
More informationTHREE BASIC APPROACHES TO MEASURING THE HRQOL IMPACT OF MEDICAL CONDITIONS
IBS and Quality of Life Olafur S. Palsson, Psy.D. Associate Professor, UNC Center for Functional GI & Motility Disorders Health problems are not limited to medical symptoms. Two individuals with the same
More informationPatient Satisfaction with IBS Symptom Relief Using a Novel Peppermint Oil Delivery System in a Randomized Clinical Trial and in the General Population
Short Communication imedpub Journals http://www.imedpub.com/ International Journal of Digestive Diseases ISSN 2472-1891 Vol. 2 No. 2: 27 http://dx.doi.org/10.4172/2472-1891.100027 Patient Satisfaction
More informationTitle: Crohn s disease and cystic fibrosis: there is still a lot to learn
Title: Crohn s disease and cystic fibrosis: there is still a lot to learn Authors: Claudio Trigo Salado, Eduardo Leo Carnerero, María Dolores de la Cruz Ramírez DOI: 10.17235/reed.2018.5725/2018 Link:
More informationEmerging Treatments for IBS-C and Clinical Trial Endpoints
Emerging Treatments for IBS-C and Clinical Trial Endpoints Lin Chang, M.D. Oppenheimer Family Center for Neurobiology of Stress David Geffen School of Medicine at UCLA Learning Objectives Describe current
More informationDiverse pathophysiologic mechanisms, alone or in combination,
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:465 469 Risk of Irritable Bowel Syndrome After an Episode of Bacterial Gastroenteritis in General Practice: Influence of Comorbidities ANA RUIGÓMEZ,* LUIS
More informationPrevalence and management of abdominal cramping and pain: a multinational survey
Alimentary Pharmacology & Therapeutics Prevalence and management of abdominal cramping and pain: a multinational survey E.M.M.QUIGLEY*,G.R.LOCKE, S. MUELLER-LISSNERà, L.G.PAULO,G.N.TYTGAT, I. HELFRICH**
More informationEffects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation
Alimentary Pharmacology and Therapeutics Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation L. Chang*, W. D. Chey, D.
More informationIntestinal, non-intestinal, and extra-digestive response to linaclotide in patients with IBS-C: results at Week 4 predict sustained response
Intestinal, non-intestinal, and extra-digestive response to linaclotide in patients with IBS-C: results at Week 4 predict sustained response Blanca Serrano, 1 Silvia Delgado-Aros, 2 Fermín Mearin, 3 Constanza
More informationAccepted Article. Questionnaires for the diagnosis of gastroesophageal reflux disease: are they really useful? Constanza Ciriza de los Ríos
Accepted Article Questionnaires for the diagnosis of gastroesophageal reflux disease: are they really useful? Constanza Ciriza de los Ríos DOI: 10.17235/reed.2016.4267/2016 Link: PDF Please cite this article
More informationEpidemiology and Impact of IBS
Epidemiology and Impact of IBS Speaker: Nicholas Talley Mayo Clinic Jacksonville, FL Epidemiology and Impact of IBS What is the worldwide prevalence of IBS? What is the natural history of IBS? What is
More informationTitle: Lower gastrointestinal bleeding as a form of presentation in an adult case of Abernethy syndrome
Title: Lower gastrointestinal bleeding as a form of presentation in an adult case of Abernethy syndrome Authors: Aida Suárez Sánchez, Lorena Solar García, Carmen María García Bernardo, Alberto Miyar de
More informationTitle: Long-term results of linaclotide in the treatment of constipation-type irritable bowel syndrome
Title: Long-term results of linaclotide in the treatment of constipation-type irritable bowel syndrome Authors: Fernando Geijo Martínez, Ana Sánchez Garrido, Héctor Marcos Prieto, Concepción Piñeiro Pérez,
More informationJ Neurogastroenterol Motil, Vol. 16 No. 2 April, 2010 DOI: /jnm Journal of Neurogastroenterology and Motility
ㅋ JNM J Neurogastroenterol Motil, Vol. 16 No. 2 April, 2010 DOI: 10.5056/jnm.2010.16.2.186 Journal of Neurogastroenterology and Motility Original Article The Differences in Prevalence and Sociodemographic
More informationDiarrhea may be: Acute (short-term, usually lasting several days), which is usually related to bacterial or viral infections.
Pediatric Gastroenterology Conditions Evaluated and Treated Having a child suffer with abdominal pain, chronic eating problems, or other gastrointestinal disorders can be a very trying time for a parent.
More informationpissn: eissn: Journal of Neurogastroenterology and Motility
JNM J Neurogastroenterol Motil, Vol. 20 No. 3 July, 2014 pissn: 2093-0879 eissn: 2093-0887 http://dx.doi.org/10.5056/jnm14022 Original Article Effects of Chili Treatment on Gastrointestinal and Rectal
More informationAccepted Article. Granulomatous appendicitis as an uncommon cause of abdominal pain. Description of a case
Accepted Article Granulomatous appendicitis as an uncommon cause of abdominal pain. Description of a case Carmen Salvia López Ramos, Ana Fuentes Coronel, Santiago Rodríguez Gómez DOI: 10.17235/reed.2015.3763/2015
More informationDisclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome
Gastrointestinal Motility Disorders & Irritable Bowel Syndrome None Disclosures Jasmine Zia, MD Acting Assistant Professor Division of Gastroenterology, University of Washington 6 th Asian Health Symposium
More informationProfessional Hypnotherapy & Hypnosis Training. Hypnotherapy & Hypnosis For IBS (Irritable Bowel Syndrome)
Professional Hypnotherapy & Hypnosis Training Hypnotherapy & Hypnosis For IBS (Irritable Bowel Syndrome) What Is IBS? (Irritable Bowel Syndrome) IBS is the term for a collection of symptoms that may include:
More informationTitle: Painless jaundice as an initial presentation of lung adenocarcinoma
Title: Painless jaundice as an initial presentation of lung adenocarcinoma Authors: Irene Andaluz García, Irene González Partida, Javier Lucas Ramos, Jorge Yebra Carmona DOI: 10.17235/reed.2018.5587/2018
More informationPost-Infectious Irritable Bowel Syndrome. John K. Marshall MD Division of Gastroenterology McMaster University
Post-Infectious Irritable Bowel Syndrome John K. Marshall MD Division of Gastroenterology McMaster University Pathogenesis of IBS Enck P. Nat Rev Dis Primers 2016;2:16014 Post-Infectious Irritable Bowel
More informationPost-infectious gastrointestinal symptoms after acute Giardiasis. A 1-year follow-up in general practice
Family Practice Advance Access published March 22, 2010 Family Practice 2010; 0:1 5 doi:10.1093/fampra/cmq005 Ó The Author 2010. Published by Oxford University Press. All rights reserved. For permissions,
More informationJournal of American Science 2017;13(6) Celiac Disease in Patients with Irritable Bowel Syndrome
Celiac Disease in Patients with Irritable Bowel Syndrome Ahmed Abdelmoaty Elnaggar, MD 1, Waleed El Nabawy, MD, Mohammed Ibrahim Atta, MD 1 Internal Medicine Department, Faculty of Medicine, Cairo University,
More informationPELVIC PAIN : Gastroenterological Conditions
PELVIC PAIN : Gastroenterological Conditions Departman Tarih Prof. A. Melih OZEL, MD Department of Gastroenterology Anadolu Medical Center Hospital Gebze Kocaeli - TURKEY Presentation plan 15 min. Introduction
More informationBloating, Flatulence, and
A 45-Year-Old Man With Recurrent Abdominal Pain, Bloating, Flatulence, and Intermittent Loose Stools Anthony J. Lembo, MD Associate Professor of Medicine Harvard Medical School Director, GI Motility Laboratory
More informationIBS - Definition. Chronic functional disorder of GI generally characterized by:
IBS - Definition Chronic functional disorder of GI generally characterized by: 3500 3000 No. of Publications 2500 2000 1500 1000 Irritable Bowel syndrome Irritable Bowel Syndrome 500 0 1968-1977 1978-1987
More informationWilliam D Chey, 1 Anthony J Lembo, 2 James A Phillips, 3 David P Rosenbaum 4
Efficacy and safety of tenapanor in patients with constipationpredominant irritable bowel syndrome: a 12-week, double-blind, placebocontrolled, randomized phase 2b trial William D Chey, 1 Anthony J Lembo,
More informationCHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University
CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University 1 Definition of FGID Chronic and recurrent symptoms of the gastrointestinal
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 June 2011
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 22 June 2011 SPASFON, film-coated tablets B/30 (CIP code: 309 860-8) SPASFON, suppositories B/10 (CIP code: 309 861-4)
More informationTitle: Hepatocellular carcinoma in patients without advanced fibrosis after eradication of HCV with antiviral treatment
Title: Hepatocellular carcinoma in patients without advanced fibrosis after eradication of HCV with antiviral treatment Authors: Yolanda Sánchez-Torrijos, Jara Eloísa Ternero Vega, Carmen Cepeda Franco
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 6 April 2011
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 6 April 2011 METEOXANE, capsules B/60 (CIP code: 306 693-3) Applicant: IPRAD Simethicone Hydrated phloroglucinol ATC
More informationPresenter. Irritable Bowel Syndrome. Objectives. Introduction. Rome Criteria. Irritable Bowel Syndrome 2/28/2018
Presenter Irritable Bowel Syndrome Current evidence for diagnosis & management Julie Daniels DNP, CNM Assistant Professor Course Coordinator of Primary Care of Women Faculty at Frontier Nursing University
More informationTitle: Linitis plastica of the colon due to metastases of invasive lobular breast carcinoma
Title: Linitis plastica of the colon due to metastases of invasive lobular breast carcinoma Authors: David Viso Vidal, Rafael Villanueva Pavón, Francisco Jorquera Plaza DOI: 10.17235/reed.2019.6065/2018
More informationApplying Case Definition Criteria to Irritable Bowel Syndrome
Clinical Medicine & Research Volume 6, Number 1:9-16 2008 Marshfield Clinic clinmedres.org Original Research Applying Case Definition Criteria to Irritable Bowel Syndrome Steven H. Yale, MD; A. Kenneth
More informationPELVIC PAIN : Gastroenterological Conditions
PELVIC PAIN : Gastroenterological Conditions Departman Tarih Prof. A. Melih OZEL, MD Department of Gastroenterology Anadolu Medical Center Hospital Gebze Kocaeli - TURKEY Presentation plan 15 min. Introduction
More informationIBS Irritable Bowel syndrome Therapeutics II PHCL 430
Salman Bin AbdulAziz University College Of Pharmacy IBS Irritable Bowel syndrome Therapeutics II PHCL 430 Email:- ahmedadel.pharmd@gmail.com Ahmed A AlAmer PharmD R.S is 32-year-old woman experiences intermittent
More informationNEL RISPETTO DELLE NUOVE DISPOSIZIONI IN MATERIA DI ECM, A SEGUITO DELL ATTUAZIONE DELL ACCORDO STATO-REGIONI DEL 5/11/09 E SUCCESSIVE
NOME E NUMERO DEL PROVIDER: I&C SRL - 5387 ECM N : 180726 TITOLO: XVII CONGRESSO NAZIONALE GISMAD SEDE: MILANO, HOTEL NHOW DATA: 09-10/03/2017 NEL RISPETTO DELLE NUOVE DISPOSIZIONI IN MATERIA DI ECM, A
More informationFUNCTIONAL GI DISORDERS ORIGINAL CONTRIBUTIONS
580 ORIGINAL CONTRIBUTIONS nature publishing group see related editorial on page x The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing
More informationIrritable bowel syndrome (IBS) is a ... PRESENTATION... Defining and Diagnosing Irritable Bowel Syndrome
... PRESENTATION... Defining and Diagnosing Irritable Bowel Syndrome Based on a presentation by Marvin M. Schuster, MD Presentation Summary Approximately 20% of the general population has irritable bowel
More informationFUNCTIONAL DISORDERS TREATMENT ADVANCES. Dr. Adriana Lazarescu MD FRCPC Director GI Motility Lab, Edmonton Associate Professor University of Alberta
FUNCTIONAL DISORDERS TREATMENT ADVANCES Dr. Adriana Lazarescu MD FRCPC Director GI Motility Lab, Edmonton Associate Professor University of Alberta Name: Dr. Adriana Lazarescu Conflict of Interest Disclosure
More informationAccepted Article. Celiac crisis in adults: a case report and review of the literature focusing in the prevention of refeeding syndrome
Accepted Article Celiac crisis in adults: a case report and review of the literature focusing in the prevention of refeeding syndrome Marcela de Almeida Menezes, Vírginia Cabral, Sônia Letícia Silva Lorena
More informationDiagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider
Diagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider Elizabeth Coss, MD General Gastroenterologist Audie Murphy Veterans Hospital UT Health This presentation does not
More informationHealth-related quality of life in adults with irritable bowel syndrome in a Mexican specialist hospital. A cross-sectional study
1130-0108/2017/109/4/265-272 Revista Española de Enfermedades Digestivas Copyright 2017. SEPD y ARÁN EDICIONES, S.L. Rev Esp Enferm Dig 2017, Vol. 109, N.º 4, pp. 265-272 ORIGINAL PAPERS Health-related
More informationAccepted Article. Fecal microbiota transplantation - something more than merely a therapeutic curiosity
Accepted Article Fecal microbiota transplantation - something more than merely a therapeutic curiosity CARLOS FERRE ARACIL, Lara Aguilera Castro, Enrique Rodriguez de Santiago, Ana García García de Paredes,
More informationAt the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS?
1 What Is IBS? At the outset, we want to clear up some terminology issues. IBS is the abbreviation that doctors use for irritable bowel syndrome, often when they are talking about people with IBS. We will
More informationUNDERSTANDING IBS AND CC Implications for diagnosis and management
UNDERSTANDING IBS AND CC Implications for diagnosis and management J. TACK, M.D., Ph.D. Department of Gastroenterology University Hospitals, K.U. Leuven Leuven, Belgium TYPES OF GASTROINTESTINAL DISORDERS
More informationPrimary Management of Irritable Bowel Syndrome
Primary Management of Irritable Bowel Syndrome Jasmine Zia, MD Acting Instructor, Division of Gastroenterology Current Concepts in Drug Therapy CME Course April 23, 2015 Irritable Bowel Syndrome (IBS)
More informationWilliam D. Chey, MD, FACG. Page 1 of ACG Midwest Regional Postgraduate Course Copyright 2016 American College of Gastroenterology
Dietary and Other Non-pharmacological Management of IBS William D. Chey, MD, FACG Nostrant Professor of Medicine Director GI Nutrition Program University of Michigan Peter Loftus, May 2, 2016 Page 1 of
More informationJNM Journal of Neurogastroenterology and Motility
JNM Journal of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol. 21 No. 4 October, 2015 pissn: 2093-0879 eissn: 2093-0887 http://dx.doi.org/10.5056/jnm15016 Original Article Validity
More informationAccepted Article. Massive gastrointestinal pneumatosis in a patient with celiac disease and superior mesenteric artery syndrome
Accepted Article Massive gastrointestinal pneumatosis in a patient with celiac disease and superior mesenteric artery syndrome Aleix Martínez-Pérez, Ramón Trullenque-Juan, Sandra Santarrufina-Martínez,
More informationAccepted Article. Cannabis intake and intussusception: an accidental association?
Accepted Article Cannabis intake and intussusception: an accidental association? Alberto Fernandez-Atutxa, Leticia de Castro, Juan Antonio Arévalo-Senra, Elena Langara, José Luis Cabriada-Nuño DOI: 10.17235/reed.2016.4288/2016
More informationRelief, true to form
For adults with Chronic Idiopathic Constipation (CIC) or Irritable Bowel Syndrome with Constipation (IBS-C) Relief, true to form When It Comes to Constipation Relief, Form Matters Trulance can help you
More informationCopyright note. Wensaas 1
Wensaas 1 Copyright note This document is a self-archived version of the paper entitled Post-infectious and sporadic functional gastrointestinal disorders have different prevalences and rates of overlap:
More informationIrritable Bowel Syndrome and Chronic Constipation. Treatment of IBS. Susan Lucak, M.D. Columbia University Medical Center
Ti tl e s l i d e - p a rt 1 Irritable Bowel Syndrome and Chronic Constipation Susan Lucak, M.D. Columbia University Medical Center Treatment of IBS Abdominal pain / discomfort Antispasmodics Antidepressants
More informationWhy does my stomach hurt? Exploring irritable bowel syndrome
Why does my stomach hurt? Exploring irritable bowel syndrome By Flavio M. Habal, MD, PhD, FRCPC Case In this article: 1. What is IBS? A 45-year-old female is referred to your office with recurrent 2. How
More informationMAYO CLINIC IRRITABLE BOWEL SYNDROME PDF
01 July, 2018 MAYO CLINIC IRRITABLE BOWEL SYNDROME PDF Document Filetype: PDF 134.23 KB 0 MAYO CLINIC IRRITABLE BOWEL SYNDROME PDF In this study, our aim was to test the hypothesis that colonic tone is
More informationXifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary
Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2 Lotronex (alosetron) a Indication For women with severe diarrheapredominant irritable
More informationIrritable bowel syndrome among nurses and nursing students in Brunei Darussalam
Original Article Brunei Int Med J. 2013; 9 (2): 102-109 Irritable bowel syndrome among nurses and nursing students in Brunei Darussalam Vui Heng CHONG Department of Medicine, RIPAS Hospital, Brunei Darussalam
More informationDOWNLOAD OR READ : IRRITABLE BOWEL SYNDROME ONE DISEASE SEVERAL OR NONE PERSPECTIVES IN DIGESTIVE DISEASES VOL 5 PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : IRRITABLE BOWEL SYNDROME ONE DISEASE SEVERAL OR NONE PERSPECTIVES IN DIGESTIVE DISEASES VOL 5 PDF EBOOK EPUB MOBI Page 1 Page 2 irritable bowel syndrome one disease several or none perspectives
More informationUnlocking the mysteries of gut comfort
Priority Research Programme Foods for improving gut function and comfort Unlocking the mysteries of gut comfort Nicole Roy, Professor AgResearch and Riddet Institute Host institution Foods for gut function
More informationMirtazapine in diarrhea-predominant irritable bowel syndrome: an openlabel
Research Article http://www.alliedacademies.org/gastroenterology-and-digestive-diseases/ Mirtazapine in diarrhea-predominant irritable bowel syndrome: an openlabel study. Sanagapalli S 1,2*, Kim E 1, Zarate-Lopez
More informationValidated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population
Aliment Pharmacol Ther 2005; 22: 483 488. doi: 10.1111/j.1365-2036.2005.02621.x Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population A. O. O.
More informationHealth-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea
Buono et al. Health and Quality of Life Outcomes (2017) 15:35 DOI 10.1186/s12955-017-0611-2 RESEARCH Open Access Health-related quality of life, work productivity, and indirect costs among patients with
More informationIBS current status Peter Laszlo Lakatos
IBS current status Peter Laszlo Lakatos Semmelweis University 1st Department of Medicine Functional gastrointestinal disorders Chronic or fluctuating functional gastrointestinal symptoms that can not be
More informationIrritable Bowel Syndrome. Mustafa Giaffer March 2017
Irritable Bowel Syndrome Mustafa Giaffer March 2017 Introduction First described in 1771. 50% of patients present
More informationLinaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation
GASTROENTEROLOGY 2010;139:1877 1886 CLINICAL Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation JEFFREY M. JOHNSTON,*
More informationBowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care
Bowel cancer risk in the under 50s Greg Rubin Professor of General Practice and Primary Care Prevalence of GI problems in the consulting population Thompson et al, Gut 2000 Number of patients % of patients
More informationThe effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study
Aliment Pharmacol Ther 2005; 22: 381 385. doi: 10.1111/j.1365-2036.2005.02566.x The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled
More informationThe role of gut microbiome in IBS
The role of gut microbiome in IBS Chung Owyang, MD H. Marvin Pollard Professor of Internal Medicine Professor of Molecular and Integrative Physiology Chief, Division of Gastroenterology Director, Pollard
More informationAccepted Manuscript. Does eradication of Helicobacter pylori cause inflammatory bowel disease? Johan Burisch, Tine Jess
Accepted Manuscript Does eradication of Helicobacter pylori cause inflammatory bowel disease? Johan Burisch, Tine Jess PII: S1542-3565(19)30153-3 DOI: https://doi.org/10.1016/j.cgh.2019.02.013 Reference:
More informationWOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN
Original Article WOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN Kassab Harfoushi 1 ABSTRACT Objectives: To characterize the possible risk factors, clinical features and outcome
More informationAccepted Manuscript. Prebiotics Versus Low Fodmap Diet: An Interpretative Nightmare. Jane Varney, Jane G. Muir, Peter R. Gibson
Accepted Manuscript Prebiotics Versus Low Fodmap Diet: An Interpretative Nightmare Jane Varney, Jane G. Muir, Peter R. Gibson PII: S0016-5085(18)35389-7 DOI: https://doi.org/10.1053/j.gastro.2018.10.060
More informationPatient Input CADTH COMMON DRUG REVIEW. VIBERZI (ELUXADOLINE) (Allergan Pharma Co.) Indication: Irritable bowel syndrome with diarrhea
CADTH COMMON DRUG REVIEW Patient Input VIBERZI (ELUXADOLINE) (Allergan Pharma Co.) Indication: Irritable bowel syndrome with diarrhea CADTH received patient input from: Gastrointestinal Society March 16,
More informationAging Persons with Intellectual Developmental Disorders (IDD): Constipation KEYPOINTS OVERVIEW
Aging Persons with Intellectual Developmental Disorders (IDD): Constipation KEYPOINTS A major medical conditions that commonly is seen among persons with IDD and may lead to serious complications is constipation.
More informationTitle: Eluxadoline in the treatment of diarrheapredominant. The SEPD perspective. Authors: Isabel Vera, F. Javier Júdez
Title: Eluxadoline in the treatment of diarrheapredominant irritable bowel syndrome. The SEPD perspective Authors: Isabel Vera, F. Javier Júdez DOI: 10.17235/reed.2017.5078/2017 Link: PubMed (Epub ahead
More informationIRONWOOD AND FOREST ANNOUNCE POSITIVE LINACLOTIDE RESULTS FROM PHASE 3 TRIAL IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION
FOR IMMEDIATE RELEASE Ironwood Contact: Forest Contact: Susan Brady Frank J. Murdolo Corporate Communications Vice President, Investor Relations 617.621.8304 212.224.6714 sbrady@ironwoodpharma.com frank.murdolo@frx.com
More informationPrevalence and demographics of irritable bowel syndrome: results from a large web-based survey
Aliment Pharmacol Ther 2005; 22: 935 942. doi: 10.1111/j.1365-2036.2005.02671.x Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey E. B. ANDREWS*, S. C. EATON*,
More informationUncomplicated diverticular disease is not a common cause of colonic symptoms
Alimentary Pharmacology and Therapeutics Uncomplicated diverticular disease is not a common cause of colonic symptoms J. Y. Kang*, B. Firwana*, A. E. Green*, H. Matthews*, A. Poullis*, A. Barnabas*, L.
More informationOvarian cyst, indigestion, constipation, back pain bloating
P ford residence southampton, ny Ovarian cyst, indigestion, constipation, back pain bloating 14-11-2017 Read about causes of symptoms and treatment of abdominal pain in adults and when to seek medical
More informationUnlocking the mysteries of gut comfort
Priority Research Programme Foods for improving gut function and comfort Unlocking the mysteries of gut comfort Nicole Roy, Professor AgResearch and Riddet Institute Host institution Foods for gut function
More informationAccepted Manuscript. Letter to the Editor. Reply to: A cut-off serum creatinine value of 1.5 mg/dl for AKI - To be or not to be
Accepted Manuscript Letter to the Editor Reply to: A cut-off serum creatinine value of 1.5 mg/dl for AKI - To be or not to be Claudia Fagundes, Rogelio Barreto, Ezequiel Rodríguez, Isabel Graupera, Esteban
More informationCOMORBIDITY OF IRRITABLE BOWEL SYNDROME, PANIC DISORDER, AND AGORAPHOBIA IN THE GENERAL POPULATION IN JAPAN
COMORBIDITY OF IRRITABLE BOWEL SYNDROME, PANIC DISORDER, AND AGORAPHOBIA IN THE GENERAL POPULATION IN JAPAN HIROAKI KUMANO, M.D. 1,2) Hisanobu Kaiya M.D. 1,2) Gaku Yamanaka M.D. 1,2,3) Tomifusa Kuboki
More informationTitle: Utility of neoadjuvant therapy in rectal GIST. Authors: Víctor López-López, Juan Ángel Fernández, Pascual Parrilla
Title: Utility of neoadjuvant therapy in rectal GIST Authors: Víctor López-López, Juan Ángel Fernández, Pascual Parrilla DOI: 10.17235/reed.2017.4751/2016 Link: PubMed (Epub ahead of print) Please cite
More informationT he irritable bowel syndrome (IBS) is a symptom complex
1703 FUNCTIONAL BOWEL DISEASE Familial aggregation of irritable bowel syndrome: a prospective study J S Kalantar, G R Locke III, A R Zinsmeister, C M Beighley, N J Talley... Gut 2003;52:1703 1707 See end
More information